Economic impact of moderate weight loss in patients with Type 2 diabetes: The Fremantle Diabetes Study

Diabet. Med. 28, 1131–1135 (2011)

[1]  J. Colquitt,et al.  The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. , 2009, Health technology assessment.

[2]  R. Collins,et al.  Medication cost savings associated with weight loss for obese non-insulin-dependent diabetic men and women. , 1995, Preventive medicine.

[3]  F. Pi‐Sunyer,et al.  Short-Term Medical Benefits and Adverse Effects of Weight Loss , 1993, Annals of Internal Medicine.

[4]  Pi-Sunyer Fx.  Short-Term Medical Benefits and Adverse Effects of Weight Loss , 1993 .

[5]  G. Reaven.  Beneficial Effect of Moderate Weight Loss in Older Patients with Non‐Insulin‐dependent Diabetes Mellitus Poorly Controlled with Insulin , 1985, Journal of the American Geriatrics Society.

[6]  T. Wadden,et al.  Treating the obese patient. Suggestions for primary care practice. , 1999, Archives of family medicine.

[7]  M K Campbell,et al.  Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. , 2004, Health technology assessment.

[8]  R. Klein,et al.  Weight change and glycemic control in a population-based sample of adults with older-onset diabetes. , 1998, The journals of gerontology. Series A, Biological sciences and medical sciences.

[9]  P. Norman,et al.  Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study. , 2006, Diabetes care.

[10]  G. Bray,et al.  Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes , 2007, Diabetes Care.

[11]  B. Goldstein,et al.  Beneficial health effects of modest weight loss. , 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[12]  R R Wing,et al.  Long-term effects of modest weight loss in type II diabetic patients. , 1987, Archives of internal medicine.

[13]  A. J. Bass,et al.  Population‐based linkage of health records in Western Australia: development of a health services research linked database , 1999, Australian and New Zealand journal of public health.

[14]  I. Mackay,et al.  Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi‐ethnic Australian community: the Fremantle Diabetes Study , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[15]  R. Clifford,et al.  Effect of insulin therapy on quality of life in Type 2 diabetes mellitus: The Fremantle Diabetes Study. , 2001, Diabetes research and clinical practice.

[16]  T. Davis,et al.  Glycemic Control in Older Subjects with Type 2 Diabetes Mellitus in the Fremantle Diabetes Study , 2000, Journal of the American Geriatrics Society.

[17]  J. Seidell,et al.  Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample , 1995, BMJ.

[18]  C. Gudex,et al.  The QALY toolkit , 1988 .

[19]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .

[20]  Goldstein Dj.  Beneficial health effects of modest weight loss , 1992 .

[21]  S. T. Buckland,et al.  An Introduction to the Bootstrap. , 1994 .

[22]  Reliability and Validity of a Diabetes Quality-of-Life Measure for the Diabetes Control and Complications Trial (DCCT) , 1988, Diabetes Care.

[23]  G. Dohm,et al.  Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. , 1992, The American journal of clinical nutrition.